8-K
Current Report
Serina Therapeutics, Inc. Filed Acc 0001493152-20-007466
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading form8-k.htm…